Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0K7RO
|
||||
| Former ID |
DNC010700
|
||||
| Drug Name |
2-morpholino-1,1-di(pyridin-3-yl)octan-1-ol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530800] | ||
| Formula |
C22H31N3O2
|
||||
| Canonical SMILES |
CCCCCCC(C(C1=CN=CC=C1)(C2=CN=CC=C2)O)N3CCOCC3
|
||||
| InChI |
1S/C22H31N3O2/c1-2-3-4-5-10-21(25-13-15-27-16-14-25)22(26,19-8-6-11-23-17-19)20-9-7-12-24-18-20/h6-9,11-12,17-18,21,26H,2-5,10,13-16H2,1H3
|
||||
| InChIKey |
PUFFDHPIZWKLSX-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Potassium voltage-gated channel subfamily A member 5 | Target Info | Inhibitor | [530800] | |
| PathWhiz Pathway | Muscle/Heart Contraction | ||||
| Reactome | Voltage gated Potassium channels | ||||
| WikiPathways | Potassium Channels | ||||
| References | |||||